uniQure (QURE) Change in Accured Expenses (2016 - 2026)
uniQure's (QURE) quarterly Change in Accured Expenses came in at $3.9 million in Q1 2026, up 423.49% year-on-year from $744624.3 in Q1 2025, and up 126.25% quarter-over-quarter from -$14.8 million in Q4 2025.
uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends
uniQure's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 423.49% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $9.6 million, a 656.48% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 179.3% from the prior year.
- Change in Accured Expenses climbed to $3.9 million in Q1 2026 per QURE's latest filing, from -$14.8 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $22.6 million in Q3 2025 and bottomed at -$14.8 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is -$248000.0 (2022), against an average of $46294.1.
- Across the five-year window, Change in Accured Expenses tumbled 682.77% in 2024 and jumped 537.32% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$248000.0 in 2022, then jumped by 373.79% to $679000.0 in 2023, then tumbled by 682.77% to -$4.0 million in 2024, then plunged by 275.21% to -$14.8 million in 2025, then jumped by 126.25% to $3.9 million in 2026.
- Per Business Quant, the three latest QURE Change in Accured Expenses figures stand at $3.9 million (Q1 2026), -$14.8 million (Q4 2025), and $22.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | uniQure | 2.41 Bn | 2.41 Bn | 3.34 Mn | 3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | -14.85 Mn |
| Dec 31, 2025 | -14.85 Mn |
| Sep 30, 2025 | 22.59 Mn |
| Sep 30, 2025 | 22.59 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -3.96 Mn |
| Dec 31, 2024 | -3.96 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Dec 31, 2023 | 679,000.00 |
| Dec 31, 2023 | 679,000.00 |